Guerbet's Telebrix 38 replacements approved:
This article was originally published in Clinica
Executive Summary
The French Health Ministry has officially withdrawn approval for Guerbet's Telebrix 38 X-ray contrast agent. The company decided to withdraw the products from sale last January as a "cautious move" following several reports of crystallisation (see Clinica No 638, p 14). The Ministry published approval for Guerbet's Telebrix 30 and Telebrix 35 contrast agents in the same ruling (Official journal of May 5th, 1995).